Fuji lands hospital as site for Synapse PACS product
Fuji lands hospital as site for Synapse PACS productFuji Medical Systems USA has taken the next step in its quest to become a full-line PACS vendor with the signing of a beta-site agreement with the Hospital of Saint Raphael in New Haven, CT.
Fuji lands hospital as site for Synapse PACS product
Fuji Medical Systems USA has taken the next step in its quest to become a full-line PACS vendor with the signing of a beta-site agreement with the Hospital of Saint Raphael in New Haven, CT. Saint Raphael will serve as the first installation for Fuji's Synapse PACS network, which the Stamford, CT, vendor rolled out last year (
PNN
12/97).
Fuji is developing Synapse as an enterprise-wide image and information management system, and Saint Raphael hopes the installation will help the hospital develop an electronic patient record. Saint Raphael already has experience as a Fuji computed radiography site, and the hospital's proximity to Fuji headquarters will facilitate the R&D process, Fuji said.
- Search again
- Homepage
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
